Drug Discovery

actavis-new-drug-application-nda-for-progestin-only-transdermal-contraceptive-patch-norethindrone-transdermal-delivery-system-gets-fda-nod

Actavis 'pregnancy preventer' gets FDA nod

  • US
  • |
  • News

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more

gilead-leukemia-study-gets-complete-repsonse

Gilead leukemia study gets complete response


  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more

bioduro-opens-discovery-lab-in-shanghai

BioDuro opens discovery lab in Shanghai


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more

hope-for-prostrate-cancer-patients-cabozantinib-slows-down-the-spread-of-the-disease

New drug slows cancer significantly

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A study by University of Michigan Comprehensive Cancer Center researchers demonstrated that a new drug has dramatic and rapid... Read more

drug-development-chugai-nippon-shinyaku

Chugai, Nippon Shinyaku tie up for drug development

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co-develop and co-market... Read more

hope-for-parkinson-s-and-alzheimer-s-disease-patients-ucla-scientists-are-developing-a-new-compound-called-clr01

UCLA finds new compound to curb Alzheimer's

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular compound, CLR01,... Read more

agreement-nanocarrier-orient

Orient, NanoCarrier sign deal for Nanoplatin trial

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreement for conducting... Read more

marvel-lifescience-withdraws-centralized-marketing-authorizations-for-human-insulins-solumarv-isomarv-and-combimarv

UK firm withdraws insulin marketing applications

  • Europe
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: UK's Marvel LifeScience, insulin marketing company, has withdrawn its application for centralized marketing authorizations for... Read more

starpharma-to-get-usd6-mn-cash-incentives-for-overseas-research-of-vivagel

Starpharma to receive $6 mn for overseas R&D

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for overseas research activities... Read more

tga-approves-genzyme-aubagio-teriflunomide-for-multiple-sclerosis-ms

Genzyme multiple sclerosis drug gets TGA nod

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian therapeutic goods administration (TGA) has approved Aubagio (teriflunomide) 14 mg as a new once-daily, oral treatment... Read more

eliquis-approved-in-eu-for-stroke-prevention

Eliquis approved in EU for stroke prevention

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: European Commission has approved Eliquis (apixaban) for prevention of stroke and systemic embolism in adult patients with nonvalvular... Read more

sihuan-pharmaceutical-and-collaborate-to-develop-ciclomulsion-and-neurostat

Sihuan, NeuroVive to develop heart and brain products

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two innovative products,... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X